– the leading provider of online annual reports to individual and institutional investors.

SemBioSys Genetics Inc.

SemBioSys Genetics Inc. is a publicly traded biotechnology company developing insulin and other protein-based pharmaceuticals that address critical unmet needs in metabolic and cardiovascular diseases.

View Online Reports: Order Free Hardcopy You can request a free hardcopy of this report mailed to you by clicking the button below.
Add Annual Report

No investor fact sheets added yet
No responsibility reports added yet

Browse Reports